En Es

Industry News

Transasia Showcases Clinical Lab Solutions at APPI 2017

By Labmedica International staff writers
16 Jun 2017

Image: The Sysmex XN-330 hematology analyzer, one of three analyzers showcased at the APPI 2017 conference (Photo courtesy of Transasia).Transasia Bio-Medicals Ltd. (Mumbai, India), an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.

Transasia, a part of the global Erba Diagnostics Mannheim GmbH Group, offers solutions and products in biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. During the three-day event, which will be attended by over 1,000 practicing pathologists from India and across the world, the company will introduce new products and processes that provide an end-to-end solution for improved lab efficiency. Transasia will be introducing Sysmex XN-330, the latest six-part differential hematology analyzer as well as showcasing the EM 200, a fully automated biochemistry analyzer, and the ECL 760 coagulation analyzer.

Additionally, Transasia will also organize interactive scientific sessions and workshops led by experienced industry veterans in the fields of hematology, biochemistry and coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges, as well as open the doors for further discussions on the best practice approaches for addressing those challenges.

E-mail Print
FaceBook Twitter Google+ Linked in


Erba Diagnostics Mannheim, a company registered in Mannheim, Germany supplies Instruments, Reagents and Consumables conforming to IVD Directives.  It is a ISO 13485 : 2003 certified company. The requisite expertise and technical edge have made Erba “The Company of Choice” for supplying instruments under OEM labels for many diagnostic companies across Europe and Asia.
Gold member
More info

Additional news

13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Read More
08 Feb 2018
AI Could Learn How to Understand Radiologist Reports
Researchers at the Icahn School of Medicine at Mount Sinai have used machine learning techniques, including natural language processing algorithms, to identify clinical concepts in radiologist reports for computed tomography (CT) scans. The technology marks an important first step in the development of artificial intelligence (AI) that could interpret scans and diagnose conditions.
Read More
08 Feb 2018
AR and VR in Healthcare Market to Reach USD 4.9 Million by 2023
The augmented reality (AR) and virtual reality (VR) in the healthcare market was valued at USD 769.2 million in 2017 and is expected to grow at a CAGR of 36.6% during the forecast period to reach USD 4,997.9 million by 2023. The market growth will be driven by increasing penetration of connected devices in the healthcare sector, rising investment in healthcare AR and VR, and growing need to reduce healthcare costs. However, the lack of competence in the deployment of AR and VR solutions, and lack of expertise among medical practitioners to adopt new technologies are the major restraints for market growth.
Read More
08 Feb 2018
Elekta Collaborates with IBM Watson Health to Bring AI to Oncology
Elekta is collaborating with IBM Watson Health to offer Watson for Oncology with its cancer care solutions. Beginning in early 2018, Elekta will sell Watson for Oncology as a clinical decision support solution, paired within its digital cancer care solutions, including the MOSAIQ Oncology Information System.
Read More
08 Feb 2018
AR System Allows Surgeons to Reconnect Blood Vessels
A team of researchers at Imperial College London at St Mary’s Hospital has demonstrated the use of Microsoft HoloLens headset for performing reconstructive lower limb surgery on patients. The HoloLens is a self-contained computer headset that immerses the wearer in ‘mixed reality’, allowing them to interact with ‘holograms’ which are computer-generated objects made visible through the visor.
Read More
29 Jan 2018
Top Drivers of Global Laboratory Centrifuge Market
The global laboratory centrifuge market is expected to grow steadily at a CAGR of more than 5% during the forecast period 2017-2022, driven mainly by the increasing number of biotechnology and pharmaceutical research studies, growing use of molecular diagnostics in hospitals, and technological advancements.
Read More
29 Jan 2018
Patient Positioning Systems Market to Reach USD 1.4 Billion by 2025
The global patient positioning systems market was valued at USD 942.8 million in 2016 and is expected to grow at a CAGR of 4.7% during the 2014 - 2025 forecast period to reach USD 1.4 billion by 2025, driven by a growing geriatric population, rising incidence of cancer, increasing awareness among patients, and surge in expenditure on diagnostic procedures. Additionally, technological advancements in sensors, such as optic fiber technology, cancer tracking sensors, and MEMS sensors, are expected to further boost the market growth.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions